Cartilage tissue engineering brings good news for patients with cartilage defects

Chondral defect is a kind of defect which refers to focal area damage to the articular cartilage. This defect also damages the bone which is lying underneath the cartilage. Symptoms indicating this condition might not occur immediately in life but chondral cartilage defects are very common. Damage in the cartilage may occur due to injury or due to wear and tear over many years. However, there are people who happen to develop symptoms but do not develop osteoarthritis.

This can be attributed to articular cartilage possessing slow self-healing properties. Due to this reason, the management and the prevention of any chondral defect turns out to be challenging. Many treatments were brought into the light (for example, a shift has occurred from symptomatic treatment to structural cartilage regeneration) but all of them produced less satisfactory to poor results. Results of a few clinical trials demonstrated that cartilage defects caused by trauma, infection, congenital malformations and tumors were most commonly encountered in patients which, therefore, had a huge negative impact on the patient's quality of life.

Due to advances in modern technology, cartilage tissue engineering has brought some good news for the patients who are going through such conditions. This review presented by Lin et al. attempts to familiarize readers with the preparation techniques and types of scaffold material which is used in cartilage tissue engineering which can be used to treat chondral defects.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Carcinotech publishes research on patient-derived 3D-printed tumors as a breakthrough tool for drug development